Compass Point Maintains FTAI Aviation(FTAI.US) With Buy Rating, Raises Target Price to $118
FTAI Aviation (FTAI) Receives a Buy From Compass Point
Insmed Analyst Ratings
Barclays Keeps Their Buy Rating on Insmed (INSM)
Goldman Sachs Raises Price Target on Insmed to $102 From $74, Maintains Buy Rating
Goldman Sachs Maintains Buy on Insmed, Raises Price Target to $102
FTAI Aviation Downgraded at Wolfe Research
FTAI Aviation Analyst Ratings
Insmed Analyst Ratings
HC Wainwright Adjusts Price Target on Insmed to $90 From $70, Maintains Buy Rating
Analysts' Opinions Are Mixed on These Healthcare Stocks: CureVac (CVAC), Insmed (INSM) and Quest Diagnostics (DGX)
Insmed (INSM) Receives a Buy From Evercore ISI
Insmed Analyst Ratings
TD Cowen Sticks to Its Buy Rating for Insmed (INSM)
Optimistic Buy Rating for Insmed's Brensocatib Based on Forthcoming ASPEN Data and Competitive Analysis
Insmed Analyst Ratings
Evercore ISI Boosts Price Target on Insmed to $75 From $42, Maintains Outperform Rating
Insmed Analyst Ratings
FTAI Aviation Analyst Ratings
FTAI Aviation Analyst Ratings